Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Employment agrmnt
Quarterly results
Credit agrmnt [a]
Appointed director

Adeptus Health Inc. (ADPT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/11/2017 EFFECT Form EFFECT - Notice of Effectiveness:
10/10/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/02/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
10/02/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/02/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/02/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/02/2017 8-K Quarterly results
09/14/2017 8-K Quarterly results
09/01/2017 8-K Quarterly results
08/02/2017 8-K Quarterly results
08/01/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Monthly Operating Report for the Period from June 1, 2017 to June 30, 2017"
07/20/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Debtors' First Amended Joint Plan of Reorganization",
"Disclosure Statement for Debtors' First Amended Joint Plan of Reorganization"
07/05/2017 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Monthly Operating Report for the Period from May 1, 2017 to May 31, 2017"
06/21/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
06/12/2017 4 Sterling Capital Partners III, LLC (10% Owner) has filed a Form 4 on Adeptus Health Inc.
Txns: Converted 1,335,068 shares @ $0
Paid exercise price by delivering 8,834 shares @ $0
Converted 1,335,068 options to buy @ $0
05/30/2017 8-K Form 8-K - Current report
05/18/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
05/16/2017 8-K Form 8-K - Current report
05/12/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
05/09/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
05/08/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
05/08/2017 GN DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Adeptus Health Inc. (ADPT) & Lead Plaintiff Deadline: May 9, 2017
05/03/2017 GN DEADLINE ALERT: Brower Piven Reminds Investors Of The Upcoming Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Adeptus Health Inc. (NYSE: ADPT) To Contact The Firm
05/02/2017 GN The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Adeptus Health Inc. Shareholders and Lead Plaintiff Deadline of May 9, 2017
05/01/2017 GN ADPT EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Adeptus Health Inc. and a Lead Plaintiff Deadline of May 9, 2017
04/28/2017 8-K Form 8-K - Current report
04/28/2017 GN INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Adeptus Health Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 9, 2017 – ADPT
04/27/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
04/25/2017 8-K Form 8-K - Current report
04/20/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
04/20/2017 8-K Form 8-K - Current report
04/18/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
04/18/2017 GN Safirstein Metcalf LLP Announces That A Class Action Lawsuit Has Been Filed Against Adeptus Health, Inc. – ADPT
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy